Literature DB >> 18343879

Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.

Mark D Eisner1, Carlos Iribarren, Edward H Yelin, Stephen Sidney, Patricia P Katz, Lynn Ackerson, Phenius Lathon, Irina Tolstykh, Theodore Omachi, Nancy Byl, Paul D Blanc.   

Abstract

The authors' objective was to analyze the impact of respiratory impairment on the risk of physical functional limitations among adults with chronic obstructive pulmonary disease (COPD). They hypothesized that greater pulmonary function decrement would result in a broad array of physical functional limitations involving organ systems remote from the lung, a key step in the pathway leading to overall disability. The authors used baseline data from the Function, Living, Outcomes, and Work (FLOW) study, a prospective cohort study of adults with COPD recruited from northern California in 2005-2007. They studied the impact of pulmonary function impairment on the risk of functional limitations using validated measures: lower extremity function (Short Physical Performance Battery), submaximal exercise performance (6-Minute Walk Test), standing balance (Functional Reach Test), skeletal muscle strength (manual muscle testing with dynamometry), and self-reported functional limitation (standardized item battery). Multiple variable analysis was used to control for confounding by age, sex, race, height, educational attainment, and cigarette smoking. Greater pulmonary function impairment, as evidenced by lower forced expiratory volume in 1 second (FEV(1)), was associated with poorer Short Physical Performance Battery scores and less distance walked during the 6-Minute Walk Test. Lower forced expiratory volume in 1 second was also associated with weaker muscle strength and with a greater risk of self-reported functional limitation (p < 0.05). In conclusion, pulmonary function impairment is associated with multiple manifestations of physical functional limitation among COPD patients. Longitudinal follow-up can delineate the impact of these functional limitations on the prospective risk of disability, guiding preventive strategies that could attenuate the disablement process.

Entities:  

Mesh:

Year:  2008        PMID: 18343879      PMCID: PMC2610529          DOI: 10.1093/aje/kwn025

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  74 in total

Review 1.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  J Vestbo; T Sørensen; P Lange; A Brix; P Torre; K Viskum
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

4.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

Authors:  R A Pauwels; C G Löfdahl; L A Laitinen; J P Schouten; D S Postma; N B Pride; S V Ohlsson
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

5.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

6.  Disability, physical activity, and muscle strength in older women: the Women's Health and Aging Study.

Authors:  T Rantanen; J M Guralnik; R Sakari-Rantala; S Leveille; E M Simonsick; S Ling; L P Fried
Journal:  Arch Phys Med Rehabil       Date:  1999-02       Impact factor: 3.966

Review 7.  Peripheral skeletal muscles and exercise performance in patients with chronic obstructive pulmonary disease.

Authors:  R Gosselink; M Decramer
Journal:  Monaldi Arch Chest Dis       Date:  1998-08

8.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

Authors:  S Bernard; P LeBlanc; F Whittom; G Carrier; J Jobin; R Belleau; F Maltais
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

9.  Grip strength changes over 27 yr in Japanese-American men.

Authors:  T Rantanen; K Masaki; D Foley; G Izmirlian; L White; J M Guralnik
Journal:  J Appl Physiol (1985)       Date:  1998-12

10.  Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease.

Authors:  Mark D Eisner; John Balmes; Patricia P Katz; Laura Trupin; Edward H Yelin; Paul D Blanc
Journal:  Environ Health       Date:  2005-05-12       Impact factor: 5.984

View more
  34 in total

1.  Influence of anxiety on health outcomes in COPD.

Authors:  Mark D Eisner; Paul D Blanc; Edward H Yelin; Patricia P Katz; Gabriela Sanchez; Carlos Iribarren; Theodore A Omachi
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

2.  Association of lung function with physical, mental and cognitive function in early old age.

Authors:  Archana Singh-Manoux; Aline Dugravot; Francine Kauffmann; Alexis Elbaz; Joel Ankri; Hermann Nabi; Mika Kivimaki; Séverine Sabia
Journal:  Age (Dordr)       Date:  2010-09-29

3.  Development of disability in chronic obstructive pulmonary disease: beyond lung function.

Authors:  Mark D Eisner; Carlos Iribarren; Paul D Blanc; Edward H Yelin; Lynn Ackerson; Nancy Byl; Theodore A Omachi; Stephen Sidney; Patricia P Katz
Journal:  Thorax       Date:  2010-11-03       Impact factor: 9.139

4.  Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort.

Authors:  Mark D Eisner; Theodore A Omachi; Patricia P Katz; Edward H Yelin; Carlos Iribarren; Paul D Blanc
Journal:  Chest       Date:  2009-12-29       Impact factor: 9.410

5.  Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?

Authors:  Bram van den Borst; Annemarie Koster; Binbing Yu; Harry R Gosker; Bernd Meibohm; Douglas C Bauer; Stephen B Kritchevsky; Yongmei Liu; Anne B Newman; Tamara B Harris; Annemie M W J Schols
Journal:  Thorax       Date:  2011-07-01       Impact factor: 9.139

6.  The COPD Helplessness Index: a new tool to measure factors affecting patient self-management.

Authors:  Theodore A Omachi; Patricia P Katz; Edward H Yelin; Carlos Iribarren; Sara J Knight; Paul D Blanc; Mark D Eisner
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

7.  COPD and cognitive impairment: the role of hypoxemia and oxygen therapy.

Authors:  Neeta Thakur; Paul D Blanc; Laura J Julian; Edward H Yelin; Patricia P Katz; Stephen Sidney; Carlos Iribarren; Mark D Eisner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

8.  Association between lung function and disability in African-Americans.

Authors:  R J Thorpe; S L Szanton; K Whitfield
Journal:  J Epidemiol Community Health       Date:  2009-03-11       Impact factor: 3.710

9.  Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?

Authors:  Theodore A Omachi; Steven E Gregorich; Mark D Eisner; Renee A Penaloza; Irina V Tolstykh; Edward H Yelin; Carlos Iribarren; R Adams Dudley; Paul D Blanc
Journal:  Med Care       Date:  2013-08       Impact factor: 2.983

10.  The impact of SHS exposure on health status and exacerbations among patients with COPD.

Authors:  Mark D Eisner; Carlos Iribarren; Edward H Yelin; Stephen Sidney; Patricia P Katz; Gabriela Sanchez; Paul D Blanc
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.